|
| 37506981 | Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial. | Int J Radiat Oncol Biol Phys | 2024 |
| 37541280 | National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. | Lancet Oncol | 2023 |
| 35849035 | Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial. | Neuro Oncol | 2023 |
| 35657335 | Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. | Neuro Oncol | 2023 |
| 36260832 | NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. | Journal of Clinical Oncology | 2023 |
| 37944590 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Nat Med | 2023 |
| 38024244 | NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma. | Neurooncol Adv | 2023 |
| 37922934 | A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. | Lancet Oncol | 2023 |
| 37657726 | Online adaptive radiotherapy: Assessment of planning technique and its impact on longitudinal plan quality robustness in pancreatic cancer. | | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 38001010 | Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer. | | 2023 |
| 37722990 | Surgically targeted radiation therapy (STaRT) for recurrent brain metastases: Initial clinical experience. | | 2023 |
| 37793574 | Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation. | | 2023 |
| 38069666 | Evaluating the Heterogeneity of Hippocampal Avoidant Whole Brain Radiotherapy Treatment Effect: A Secondary Analysis of NRG CC001. | | 2023 |
| 37953242 | Tumor treating fields: narrative review of a promising treatment modality for cancer. | | 2023 |
| 37415385 | A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife<sup>®</sup> Icon⿢. | J Appl Clin Med Phys | 2023 |
| 37150264 | Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. | Int J Radiat Oncol Biol Phys | 2023 |
| 36966049 | Treatment of glioblastoma using MRIdian® A3i BrainTx⿢: Imaging and treatment workflow demonstration. | | 2023 |
| 36773828 | Developing an AI-assisted planning pipeline for hippocampal avoidance whole brain radiotherapy. | | 2023 |
| 36765738 | Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases. | Cancers (Basel) | 2023 |
| 36645373 | Rethinking classification and categorization of resection extent and its impact on patient survival in glioblastoma: Was Walter Dandy ahead of his time? | | 2023 |
| 37330328 | Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer. | | 2023 |
| 36881804 | The Rationale for Radiation Therapy in Alzheimer's Disease. | | 2023 |
| 37197630 | Evaluating the intracranial activity of adagrasib. | | 2023 |
| 36566577 | Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States. | | 2023 |
| 37124499 | Editorial: Effects of radiation therapies on brain metastases. | Front Oncol | 2023 |
| 36993741 | Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. | Res Sq | 2023 |
| 37172757 | Benchmarking the Radiation Oncology Alternative Payment Model: Changes in Medicare Reimbursement for 16 Common Radiation Therapy Treatment Courses. | Pract Radiat Oncol | 2023 |
| 37358937 | Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas. | Neurooncol Adv | 2023 |
| 36990614 | Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference. | Lancet Oncol | 2023 |
| 36855958 | OptImal Gamma kNife lIghTnIng sOlutioN (IGNITION) score to characterize the solution space of the Gamma Knife FIP optimizer for stereotactic radiosurgery. | J Appl Clin Med Phys | 2023 |
| 36725166 | Modern Meningioma Methods: Molecular Diagnostics and High Dose Protons. | | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 34696931 | Systematic evaluation and plan quality assessment of the Leksell® gamma knife® lightning dose optimizer. | Med Dosim | 2022 |
| 35772444 | <sup>68</sup>Ga-DOTATATE PET: The Future of Meningioma Treatment. | Int J Radiat Oncol Biol Phys | 2022 |
| 35454925 | Feasibility of Tumor Treating Fields with Pemetrexed and Platinum-Based Chemotherapy for Unresectable Malignant Pleural Mesothelioma: Single-Center, Real-World Data. | Cancers | 2022 |
| 35960905 | Access to Radiation Therapy: From Local to Global and Equality to Equity. | JCO Global Oncology | 2022 |
| 35647412 | Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy for Non-bone Oligometastases. | Advances in Radiation Oncology | 2022 |
| 35762249 | Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. | Neuro Oncol | 2022 |
| 35884453 | Zero Setup Margin Mask versus Frame Immobilization during Gamma Knife<sup>®</sup> Icon⿢ Stereotactic Radiosurgery for Brain Metastases. | Cancers (Basel) | 2022 |
| 35740612 | Pulsed-Reduced Dose Rate (PRDR) Radiotherapy for Recurrent Primary Central Nervous System Malignancies: Dosimetric and Clinical Results. | Cancers | 2022 |
| 36134014 | Optimizing the radiotherapy treatment planning process for glioblastoma. | Neuro-Oncology Practice | 2022 |
| 35731991 | Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. | J Clin Oncol | 2022 |
| 35787927 | Deep Learning-Based Automatic Detection of Brain Metastases in Heterogenous Multi-Institutional Magnetic Resonance Imaging Sets: An Exploratory Analysis of NRG-CC001. | International Journal of Radiation Oncology Biology Physics | 2022 |
| 35544650 | Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis. | JCO Oncol Pract | 2022 |
| 36420209 | Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933. | Advances in Radiation Oncology | 2022 |
| 35662657 | Dedicated isotropic 3-D T1 SPACE sequence imaging for radiosurgery planning improves brain metastases detection and reduces the risk of intracranial relapse. | Radiother Oncol | 2022 |
| 36466748 | Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments. | Clin Transl Radiat Oncol | 2022 |
| 35296750 | Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases. | Sci Rep | 2022 |
| 35288636 | Hospitalization rates from radiotherapy complications in the United States. | Scientific Reports | 2022 |